White matter hyperintensities are more highly associated with preclinical Alzheimer's disease than imaging and cognitive markers of neurodegeneration

INTRODUCTION: Cognitive tests and nonamyloid imaging biomarkers do not consistently identify preclinical AD. The objective of this study was to evaluate whether white matter hyperintensity (WMH) volume, a cerebrovascular disease marker, is more associated with preclinical AD than conventional AD bio...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Alzheimers Dement (Amst)
Auteurs principaux: Kandel, Benjamin M., Avants, Brian B., Gee, James C., McMillan, Corey T., Erus, Guray, Doshi, Jimit, Davatzikos, Christos, Wolk, David A.
Format: Artigo
Langue:Inglês
Publié: Elsevier 2016
Sujets:
Neuroimaging
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4950175/
https://ncbi.nlm.nih.gov/pubmed/27489875
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dadm.2016.03.001
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires